Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-06-19Clinical Trial Update: Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating intravenous allopurinol to improve heart function in dilated cardiomyopathy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Integrated Cardiac Care and Palliative Homecare for Patients With Severe Heart Failure [NA]
A completed clinical trial assessing integrated cardiac care and palliative homecare for patients with chronic heart failure.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Evaluation of Myocardial Viability by Means of Low-dose Dobutamine Gated SPECT (the DOGS Study)
This completed clinical trial evaluated myocardial viability using low-dose dobutamine gated SPECT (the DOGS study).
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Effectiveness of Peer Support in Improving Heart Failure Self-Management and Care [NA]
A completed clinical trial evaluating whether peer support improves self-management and care in patients with heart failure.
-
FDA approval · 2013-06-12FDA Approved: ALDACTONE — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Aldactone (spironolactone) from Pfizer. The approval updates the drug’s labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-11Clinical Trial Update: Effect of Ganglionar Electrical Stimulation on Central Arterial Pressure [NA]
The University of Brasilia completed a clinical trial evaluating ganglionar electrical stimulation on central arterial pressure in patients …
-
CLINICAL_TRIALS research · 2013-06-10Clinical Trial Update: The Effect of a Five Week Electrical Myostimulation Program in Chronic Diseases [NA]
Clinical trial update on a five-week electrical myostimulation program for chronic diseases, including heart failure. The current study stat…
-
CLINICAL_TRIALS research · 2013-06-07Clinical Trial Update: Educational Program to Improve Heart Failure Outcomes in Adults Living in Rural Areas [Phase 3]
Phase 3 clinical trial evaluating an educational program to improve heart failure outcomes in adults living in rural areas has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-06Clinical Trial Update: Metformin in Insulin Resistant Left Ventricular (LV) Dysfunction (TAYSIDE Trial) [Phase 4]
A Phase 4 trial (TAYSIDE) evaluating metformin in insulin-resistant left ventricular dysfunction associated with congestive heart failure ha…
-
CLINICAL_TRIALS research · 2013-06-06Clinical Trial Update: Renal Denervation in Patients With Heart Failure and Severe Left Ventricular Dysfunction. [NA]
This document reports a clinical trial investigating renal denervation in patients with heart failure and severe left ventricular dysfunctio…
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: IVR-Enhanced Care Transition Support for Complex Patients [NA]
This clinical trial evaluated IVR-Enhanced Care Transition Support for complex patients with congestive heart failure and COPD, with results…
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: Interpersonal Psychotherapy for Depression in People With Heart Failure [Phase 1, Phase 2]
A clinical trial evaluating interpersonal psychotherapy for depression in people with heart failure has completed Phase 1 and Phase 2.
-
CLINICAL_TRIALS research · 2013-05-30Clinical Trial Update: Multimodal Approach of Undernutrition in Chronic Heart Failure [NA]
This entry describes an investigational trial examining a multimodal approach to undernutrition in chronic heart failure, with the trial sta…
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Pacing for Heart Failure With Preserved Ejection Fraction [NA]
Medtronic-sponsored clinical trial evaluating pacing for heart failure with preserved ejection fraction has completed.
-
CLINICAL_TRIALS research · 2013-05-29Clinical Trial Update: The Role of Alcohol Consumption in the Aetiology of Different Cardiovascular Disease Phenotypes: a CALIBER Study
An update on a CALIBER observational study examining how alcohol consumption may influence the development of different cardiovascular disea…
-
CLINICAL_TRIALS trial_result · 2013-05-27Clinical Trial Update: Determining Optimal Dose and Duration of Diuretic Treatment in People With Acute Heart Failure (The DOSE-AHF Study) [Phase 3]
Phase 3 DOSE-AHF trial update examining the optimal dose and duration of intravenous diuretic therapy in patients with acute heart failure.
-
CLINICAL_TRIALS research · 2013-05-22Clinical Trial Update: Correlation of Intrathoracic Impedance Measures With Blood Plasma Volume in Congestive Heart Failure
This clinical trial update investigates the correlation between intrathoracic impedance measures and blood plasma volume in patients with co…
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients [NA]
Clinical trial evaluating discharge counseling and medication therapy management after discharge for heart failure patients has been termina…
-
FDA label_change · 2013-05-21FDA Approved: LANOXIN — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approved a supplemental label change for Lanoxin (digoxin) submitted by Advanz Pharma (US) Corp.
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: Losartan in Decompensated Heart Failure [Phase 4]
Phase 4 trial evaluating losartan in decompensated heart failure has completed. The sponsor listed is InCor Heart Institute.
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: Safety and Efficacy Study of Add On Aliskiren in Patients With Heart Failure and Renal Impairment [Phase 2]
Phase 2 trial evaluating add-on aliskiren in patients with heart failure and kidney failure has been terminated.
-
FDA approval · 2013-05-16FDA Approved: LANOXIN — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for LANOXIN (digoxin) submitted by Covis Pharma US, Inc.
-
FDA label_change · 2013-05-16FDA Approved: EPLERENONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Eplerenone by Mylan Pharmaceuticals, typically indicating labeling updates.
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Heart Failure [Phase 1, Phase 2]
A Phase 1/2 pilot clinical trial evaluated the safety and potential efficacy of Anakinra (interleukin-1 receptor antagonist) in patients wit…
-
CLINICAL_TRIALS research · 2013-05-16Clinical Trial Update: The Role of Clinical Pharmacist in Management of DDIs in CHF Patients [NA]
This clinical trial update examines the role of a clinical pharmacist in managing drug-drug interactions in patients with chronic heart fail…